Trial Profile
Efficacy of brodalumab in patients with psoriasis with failure of other anti-IL-17 treatments
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2022
Price :
$35
*
At a glance
- Drugs Brodalumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 01 Jun 2022 Results assessing circulating brodalumab levels and therapy outcomes in patients with psoriasis treated with brodalumab, published in the JAMA Dermatology.
- 13 May 2021 Status changed from recruiting to completed.
- 25 Apr 2021 Results presented at the American Academy of Dermatology Virtual Meeting Experience 2021